Fact checked by Nick Blackmer One in five adults over age 60 takes fish oil, a supplement extracted from the tissues of fatty ...

Fish oil supplementation showed efficacy in reducing risks for cardiovascular events for patients on dialysis, according to ...

Canada: A large randomized trial presented at the American Society of Nephrology’s Kidney Week has found that fish oil ...

Over 3.5 years, patients randomized to 4 g of daily fish oil had a 43% lower risk for a composite of serious cardiovascular ...

Loss of ALOX15, which frequently occurs in colorectal tumors, reduces the cancer-preventive benefits of fish oil. An estimated 19 million adults in the United States regularly take fish oil ...

A major clinical trial shows high-dose fish oil significantly reduces cardiovascular events in hemodialysis patients, ...

Previous studies have found fish oils can promote muscle gain and fat loss, but the results were inconsistent overall. In a study published in the Advances in Nutrition journal, researchers from ...

Substantial reductions in adverse cardiovascular outcomes are especially notable for this high-risk population, but ...

In this video, Jeffrey S. Berns, MD, discusses results of the PISCES study, presented at ASN Kidney Week, that found daily fish oil supplementation reduced serious cardiovascular event rates for ...

Unlike the general population, patients on maintenance hemodialysis have both traditional and nontraditional risk factors that put them at high cardiovascular risk, despite use of standard lipid and ...

With such a large reduction, coupled with general skepticism around PUFAs, experts would like to see the trial replicated.